Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.68%.

  • Harvard Bioscience's Return on Assets fell 5700.0% to 0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year decrease of 5700.0%. This contributed to the annual value of 0.09% for FY2024, which is 700.0% down from last year.
  • Harvard Bioscience's Return on Assets amounted to 0.68% in Q3 2025, which was down 5700.0% from 0.72% recorded in Q2 2025.
  • Harvard Bioscience's 5-year Return on Assets high stood at 0.0% for Q4 2021, and its period low was 0.72% during Q2 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.04% (2022), whereas its average is 0.14%.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 500bps in 2021, then crashed by -6400bps in 2025.
  • Over the past 5 years, Harvard Bioscience's Return on Assets (Quarter) stood at 0.0% in 2021, then plummeted by -1543bps to 0.07% in 2022, then soared by 64bps to 0.02% in 2023, then tumbled by -284bps to 0.1% in 2024, then crashed by -612bps to 0.68% in 2025.
  • Its Return on Assets stands at 0.68% for Q3 2025, versus 0.72% for Q2 2025 and 0.56% for Q1 2025.